Cargando…
Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
This study aimed to determine the association between umbilical cord leucine-rich alpha-2 glycoprotein (LRG) and fetal infection and investigate the underlying mechanism of LRG elevation in fetuses. We retrospectively reviewed the medical records of patients who delivered at Osaka University Hospita...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676652/ https://www.ncbi.nlm.nih.gov/pubmed/33211747 http://dx.doi.org/10.1371/journal.pone.0242076 |
_version_ | 1783611814501679104 |
---|---|
author | Kajimoto, Etsuko Endo, Masayuki Fujimoto, Minoru Matsuzaki, Shinya Fujii, Makoto Yagi, Kazunobu Kakigano, Aiko Mimura, Kazuya Tomimatsu, Takuji Serada, Satoshi Takeuchi, Makoto Yoshino, Kiyoshi Ueda, Yutaka Kimura, Tadashi Naka, Tetsuji |
author_facet | Kajimoto, Etsuko Endo, Masayuki Fujimoto, Minoru Matsuzaki, Shinya Fujii, Makoto Yagi, Kazunobu Kakigano, Aiko Mimura, Kazuya Tomimatsu, Takuji Serada, Satoshi Takeuchi, Makoto Yoshino, Kiyoshi Ueda, Yutaka Kimura, Tadashi Naka, Tetsuji |
author_sort | Kajimoto, Etsuko |
collection | PubMed |
description | This study aimed to determine the association between umbilical cord leucine-rich alpha-2 glycoprotein (LRG) and fetal infection and investigate the underlying mechanism of LRG elevation in fetuses. We retrospectively reviewed the medical records of patients who delivered at Osaka University Hospital between 2012 and 2017 and selected those with histologically confirmed chorioamnionitis (CAM), which is a common pregnancy complication that may cause neonatal infection. The participants were divided into two groups: CAM with fetal infection (CAM-f[+] group, n = 14) and CAM without fetal infection (CAM-f[−] group, n = 31). Fetal infection was defined by the histological evidence of funisitis. We also selected 50 cases without clinical signs of CAM to serve as the control. LRG concentrations in sera obtained from the umbilical cord were unaffected by gestational age at delivery, neonatal birth weight, nor the presence of noninfectious obstetric complications (all, p > 0.05). Meanwhile, the LRG levels (median, Interquartile range [IQR]) were significantly higher in the CAM-f(+) group (10.37 [5.21–13.7] μg/ml) than in the CAM-f(−) (3.61 [2.71–4.65] μg/ml) or control group (3.39 [2.81–3.93] μg/ml; p < 0.01). The area under the receiver operating characteristic (ROC) curve of LRG for recognizing fetal infection was 0.92 (optimal cutoff, 5.08 μg/ml; sensitivity, 86%; specificity, 88%). In a mouse CAM model established by lipopolysaccharide administration, the fetal LRG protein in sera and LRG mRNA in the liver were significantly higher than those in phosphate-buffered saline (PBS)-administered control mice (p < 0.01). In vitro experiments using a fetal liver-derived cell line (WRL68) showed that the expression of LRG mRNA was significantly increased after interleukin (IL)-6, IL-1β, and tumor necrosis factor- alpha (TNF-α) stimulation (p < 0.01); the induction was considerably stronger following IL-6 and TNF-α stimulation (p < 0.01). In conclusion, LRG is an effective biomarker of fetal infection, and fetal hepatocytes stimulated with inflammatory cytokines may be the primary source of LRG production in utero. |
format | Online Article Text |
id | pubmed-7676652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-76766522020-12-02 Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection Kajimoto, Etsuko Endo, Masayuki Fujimoto, Minoru Matsuzaki, Shinya Fujii, Makoto Yagi, Kazunobu Kakigano, Aiko Mimura, Kazuya Tomimatsu, Takuji Serada, Satoshi Takeuchi, Makoto Yoshino, Kiyoshi Ueda, Yutaka Kimura, Tadashi Naka, Tetsuji PLoS One Research Article This study aimed to determine the association between umbilical cord leucine-rich alpha-2 glycoprotein (LRG) and fetal infection and investigate the underlying mechanism of LRG elevation in fetuses. We retrospectively reviewed the medical records of patients who delivered at Osaka University Hospital between 2012 and 2017 and selected those with histologically confirmed chorioamnionitis (CAM), which is a common pregnancy complication that may cause neonatal infection. The participants were divided into two groups: CAM with fetal infection (CAM-f[+] group, n = 14) and CAM without fetal infection (CAM-f[−] group, n = 31). Fetal infection was defined by the histological evidence of funisitis. We also selected 50 cases without clinical signs of CAM to serve as the control. LRG concentrations in sera obtained from the umbilical cord were unaffected by gestational age at delivery, neonatal birth weight, nor the presence of noninfectious obstetric complications (all, p > 0.05). Meanwhile, the LRG levels (median, Interquartile range [IQR]) were significantly higher in the CAM-f(+) group (10.37 [5.21–13.7] μg/ml) than in the CAM-f(−) (3.61 [2.71–4.65] μg/ml) or control group (3.39 [2.81–3.93] μg/ml; p < 0.01). The area under the receiver operating characteristic (ROC) curve of LRG for recognizing fetal infection was 0.92 (optimal cutoff, 5.08 μg/ml; sensitivity, 86%; specificity, 88%). In a mouse CAM model established by lipopolysaccharide administration, the fetal LRG protein in sera and LRG mRNA in the liver were significantly higher than those in phosphate-buffered saline (PBS)-administered control mice (p < 0.01). In vitro experiments using a fetal liver-derived cell line (WRL68) showed that the expression of LRG mRNA was significantly increased after interleukin (IL)-6, IL-1β, and tumor necrosis factor- alpha (TNF-α) stimulation (p < 0.01); the induction was considerably stronger following IL-6 and TNF-α stimulation (p < 0.01). In conclusion, LRG is an effective biomarker of fetal infection, and fetal hepatocytes stimulated with inflammatory cytokines may be the primary source of LRG production in utero. Public Library of Science 2020-11-19 /pmc/articles/PMC7676652/ /pubmed/33211747 http://dx.doi.org/10.1371/journal.pone.0242076 Text en © 2020 Kajimoto et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kajimoto, Etsuko Endo, Masayuki Fujimoto, Minoru Matsuzaki, Shinya Fujii, Makoto Yagi, Kazunobu Kakigano, Aiko Mimura, Kazuya Tomimatsu, Takuji Serada, Satoshi Takeuchi, Makoto Yoshino, Kiyoshi Ueda, Yutaka Kimura, Tadashi Naka, Tetsuji Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title | Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title_full | Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title_fullStr | Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title_full_unstemmed | Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title_short | Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
title_sort | evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676652/ https://www.ncbi.nlm.nih.gov/pubmed/33211747 http://dx.doi.org/10.1371/journal.pone.0242076 |
work_keys_str_mv | AT kajimotoetsuko evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT endomasayuki evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT fujimotominoru evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT matsuzakishinya evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT fujiimakoto evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT yagikazunobu evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT kakiganoaiko evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT mimurakazuya evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT tomimatsutakuji evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT seradasatoshi evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT takeuchimakoto evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT yoshinokiyoshi evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT uedayutaka evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT kimuratadashi evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection AT nakatetsuji evaluationofleucinerichalpha2glycoproteinasabiomarkeroffetalinfection |